Isabel Mestres, CEO of City Cancer Challenge, shared on LinkedIn:
“Should C/Can expand to the United States?
Not a question I expected to come back with after a week in Washington DC. But here we are!
From the Milken Institute’s Future of Health Summit to the Women’s Health Network, chaired by Dr. Jill Biden, I had the privilege of exchanging ideas with remarkable people, including Jarbas Barbosa da Silva Jr and Santiago Cornejo at PAHO, Javier Guzman at Inter-American Development Bank, Mike Milken and the World Bank Group, philanthropists, industry and our partners at MSD, Amgen and AstraZeneca.
I also joined the panel ‘From Delivery to Discovery:
The Next Frontier in Cancer Innovation’ moderated by Greg Simon where I shared a message I feel strongly about:The next frontier in cancer innovation is implementation.
We could be preventing around 4.5 million cancer deaths every year with the knowledge and tools we already have. The challenge is getting them to patients.
What surprised me was how strongly this resonated with the US audience. Many underserved communities in the US face barriers remarkably similar to those we see in lower-resource countries: late diagnosis, fragmented services and unequal access.
So perhaps the lessons we’ve learned in cities around the world could also help the most vulnerable communities in the US?
I read your thoughts.”

Other articles about Isabel Mestres on OncoDaily.